Right Drug in the Wrong Place: The Effects of Inadvertent Intrathecal Tranexamic Acid.

Tranexamic acid (TXA) is an antifibrinolytic drug widely used to reduce blood loss in major surgeries and trauma patients, thus reducing morbimortality. In recent years, clinical indications for TXA have expanded, including many off-label uses. This broad use has led to an increased incidence of reported side effects and administration errors with serious neurological and cardiovascular outcomes, such as seizures, myoclonus, and arrhythmias.

Evidence and Case Report in a Portuguese Hospital: Is Therapeutic Ultrasound a Viable Solution in the Treatment of Mastitis?

Mastitis is a very common maternal complication of lactation and contributes to early cessation of breastfeeding. Therapeutic ultrasound has been proposed as a non-invasive therapeutic alternative and has been added to the latest recommendations aimed at the treatment of mastitis spectrum disorders. In this article, we highlight the successful utilization of therapeutic ultrasound as part of the therapeutic program after the diagnosis of mastitis in a woman who was breastfeeding three newborn children.

Navigating the brain and aging: exploring the impact of transposable elements from health to disease.

Transposable elements (TEs) are mobile genetic elements that constitute on average 45% of mammalian genomes. Their presence and activity in genomes represent a major source of genetic variability. While this is an important driver of genome evolution, TEs can also have deleterious effects on their hosts.

Complete Distal Rupture of the Rectus Femoris in an Elite Football Player: A Non-operative Treatment.

Although muscle injuries represent the most frequent injury in professional football, isolated complete distal ruptures of the rectus femoris (RF) muscle are rare, and there is no consensus on their treatment and return to play (RTP). In this article, we report a clinical case of successful non-surgical management of an RF grade 4c muscle injury in a professional football player, in which the athlete was able to RTP 21 weeks after the injury, had no re-injury >1 year after RTP, and is playing at an elite level in the Portuguese Football First League.

Return to Play After the Diagnosis of Reactive Arthritis in a Professional Football Player.

In professional football, most of the injuries are traumatic; however, these athletes may suffer from rheumatologic diseases, that may present as sports-related injuries. Reactive arthritis (ReA) is classified as a sub-group of the spondyloarthritis family and is relatively rare. In this article, we highlight the successful return to play (RTP) process after the ReA diagnosis in an elite football player in the Portuguese first league.